Inovio Pharmaceuticals(INO) - 2025 Q4 - Earnings Call Transcript

Inovio Pharmaceuticals (NasdaqCM:INO) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Company ParticipantsJackie Shea - President and CEOMike Sumner - Chief Medical OfficerPeter Kies - CFOSteve Egge - Chief Commercial OfficerNone - Company RepresentativeConference Call ParticipantsJay Olson - Managing Director and Senior AnalystTed Tenthoff - Managing Director and Senior Research AnalystNone - AnalystNone - AnalystNone - AnalystOperatorAfternoon, ladies and gentlemen, and welcome to the INOVIO fourth quart ...